Kidney rules exempt oral meds from Amgen, Genzyme - FiercePharma PDF Print
FiercePharmaThere's a silver lining in new Medicare rules for dialysis patients for Amgen (NASDAQ: AMGN), which stands to lose a big chunk of sales of its IV anemia

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.